USDM Announces Strategic Partnership With Accelrys Strengthening Lab Practice Offerings Through Innovation; New Industry Collaboration Will Accelerate Deployment of Best-in-Breed, Compliant Informatics Technology for the Life Sciences
(firmenpresse) - SANTA BARBARA, CA -- (Marketwire) -- 03/20/13 -- , a leading global regulatory consulting firm in the life sciences space, is proud to announce their strategic partnership with . (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software.
"USDM is excited to partner with Accelrys to bring innovation to the lab," said Diane Gleinser, vice president of . "Accelrys' products, combined with USDM's regulatory knowledge and life science experience, are changing the way labs operate. Efficiency and compliance now go hand in hand to reduce costs and increase productivity."
"Accelrys partnering with USDM is a win-win for life sciences organizations in regulated environments," said Ken Rapp, managing director of Accelrys ADQM Solutions. "The combination of Accelrys' market-leading process management and compliance products and services with USDM's best-practice regulatory compliance and risk management solutions returns data control and process monitoring to the scientists who are in need of harmonized capabilities in these critical areas."
Supporting these technology offerings, USDM brings a strong, proven professional services organization to assist customers in qualification, validation, auditing, risk management and other compliance-related projects, including implementation and IT architecture services for Accelrys LIMS. Together, the Accelrys and USDM team will perform all needed preliminary project/business needs assessments, piloting of the solution, initial deployments with qualification/validation and roll-out to the customer site, multiple sites or global operations.
:
is a leading global regulatory consulting firm providing compliance, business intelligence, validation, qualification, quality, auditing, and IT services to our clients in the life sciences industries. USDM has partnerships, expertise and solutions for critical Life Science technologies -- Oracle, SAP, ServiceMax, Salesforce, Microsoft, Qumas, and others. USDM has more than 12 years of experience supplying our clients with compliant solutions in each phase of their drug and product development cycle, partnering with best of breed ISVs to help companies unify and optimize their business and compliance processes. USDM provides a comprehensive enterprise solution to support US, EMEA, and Asian regulatory requirements for regulated applications.
. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, supports industries and organizations that rely on scientific innovation to differentiate themselves. The industry-leading Accelrys Enterprise Platform provides a broad and flexible scientific solution optimized to integrate the diversity of science, experimental processes and information requirements across the research, development, process scale-up and early manufacturing phases of product development. By incorporating capabilities in applications for modeling and simulation, enterprise lab management, workflow and automation, and data management and informatics, Accelrys enables scientific innovators to access, organize, analyze and share data in unprecedented ways, ultimately enhancing innovation, improving productivity and compliance, reducing costs and speeding time from lab to market. For more information about Accelrys, visit .
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 20.03.2013 - 13:03 Uhr
Sprache: Deutsch
News-ID 241383
Anzahl Zeichen: 0
contact information:
Town:
SANTA BARBARA, CA
Kategorie:
Networking
Diese Pressemitteilung wurde bisher 227 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"USDM Announces Strategic Partnership With Accelrys Strengthening Lab Practice Offerings Through Innovation; New Industry Collaboration Will Accelerate Deployment of Best-in-Breed, Compliant Informatics Technology for the Life Sciences"
steht unter der journalistisch-redaktionellen Verantwortung von
US Data Management (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
